Drugs

Xyris Corporation Appoints Leo Kim as Chief Technical Officer

Strategic Insights

Nov 23, 1998 — 1 min read

Xyris Corporation, the agricultural biotechnology affiliate of Axys Pharmaceuticals, has announced the appointment of Leo Kim, Ph.D., as its new chief technical officer. Dr. Kim joins Xyris after serving as executive vice president and chief technical officer at Mycogen Corporation, where he was instrumental in building the company into a leader in the agricultural industry. In his new role, Dr. Kim will oversee Xyris' overall research efforts and report directly to Jerry Caulder, Ph.D., Xyris' chairman and chief executive officer.

Key Takeaways:

Dr. Leo Kim, a renowned scientist with over 20 years of experience, has joined Xyris as chief technical officer, bringing expertise in development, implementation of worldwide research strategies, and leadership in proprietary science.
Dr. Kim's experience at Mycogen Corporation, where he was instrumental in building the company into an industry leader, is expected to be valuable in helping Xyris grow and develop its technology platform.
Xyris Corporation, formed in May 1998, is a majority-owned agricultural biotechnology subsidiary of Axys Pharmaceuticals, Inc. (Nasdaq:AXPH), focused on creating products for crop protection, crop improvements, animal health, and human nutrition.
Axys Pharmaceuticals, Inc. has a strong track record of integrating life science technologies, with research collaborations with world-class pharmaceutical companies in areas such as respiratory, cardiovascular, and infectious disease.
Dr. Kim has over 50 publications and patents to his name, demonstrating his significant contributions to the field of biotechnology.

Statistics:

Xyris Corporation was formed in May 1998.
Dr. Kim has over 20 years of relevant industry experience.
Dr. Kim has over 50 publications and patents to his name.
Axys Pharmaceuticals has research collaborations with world-class pharmaceutical companies in various therapeutic areas.

Sources:

BW HealthWire, "Xyris Corporation Appoints Leo Kim as Chief Technical Officer", Nov. 24, 1998.
Axys Pharmaceuticals, Inc. website, http://www.axyspharm.com (cited in the original text).

The End of American Hypergrowth

For two centuries, the US economy grew by adding workers. That's over.

Healthcare's $5.3 Trillion Drag

How Medical Spending Became America's Biggest Productivity Tax

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Researchers at the Wuhan University of Technology in China have made significant progress in the field of nanotechnology, specifically in the area of nanoindentation. A novel electromagnetic shock treatment (EST) method has been developed to enhance the microscale mechanical properties of a titanium alloy, with promising results obtained through array-based

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients

Research investigators at the Zhengzhou Central Hospital Affiliated to Zhengzhou University have made groundbreaking discoveries on the role of gut microbiota in determining the efficacy of immunotherapy for colon cancer patients. The study, which was recently published in Biochimica et Biophysica Acta, reveals that specific bacterial species and microbial metabolites

Read more

The End of American Hypergrowth

Healthcare's $5.3 Trillion Drag

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients